Q&A on practical aspects related to the implementation of the Article 10a obligation in case of interruption or discontinuation of supply of certain devices as introduced by Regulation (EU) 2024/1860 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices
News & Trends
Procurar
Recentes
- EMVO Systems Updates | May 2026
- EU agrees to simplify AI rules to boost innovation and ban ‘nudification’ apps to protect citizens
- Formação DIGITAL PROMO REVIEW : ” Formação muito interativa , bem estruturada e com elevada partilha de casos práticos “
- Best Practice Guidance for the Submission of Technical Documentation under Annex II and III of Medical Device Regulation
- COMMISSION IMPLEMENTING REGULATION laying down certain uniform quality management and procedural requirements for the conformity assessment activities carried out by a notified body designated
- MASTER COURSE SUPLEMENTOS ALIMENTARES : “Evento muito bem organizado, conduzido e menistrado “
- Guidelines on the best practices for the traceability of medicines in hospital settings
- MDCG 2021-12 Rev.2 FAQ on the European Medical Device Nomenclature (EMDN) Revision 2 – April 2026

